New Industry Czar Vows to Balance Interests of Innovative Pharma, Gx Businesses as Budget Debate Creates Divide

FPMAJ Chairman Sunao Manabe Innovative pharma companies and generic makers often have clashing interests when it comes to debates on where to best allocate limited budgets, but the new chief of the FPMAJ - an umbrella organ of all drug...read more